The association of hypoglycemia with stroke risk: A systematic review and meta-analysis
Keywords:
hypoglycemia, mortality, risk, strokeAbstract
Background and aim: The prevalence of stroke continues to increase worldwide, and optimal glucose control remains an important component of acute stroke management. However, the occurrence of hypoglycemia in patients with stroke, particularly hypoglycemia-induced stroke mimics, and its association with mortality remain controversial. This study was conducted to evaluate the occurrence of hypoglycemia in stroke patients, and to assess its association with mortality.
Methods: This systematic review and meta-analysis followed PRISMA guidelines and was registered in PROSPERO (CRD420261306540). PubMed, Scopus, ScienceDirect, Taylor and Francis, ProQuest, EBSCO, and Springer were searched for English-language observational studies involving adults.
Results: A total of 11 studies with 2,024,725 participants were involved. Hypoglycemia was significantly correlated with an increased risk of stroke, with a relative risk (RR) of 1.73 (95% confidence interval [CI]: 1.35–2.22; 95% prediction interval [PI]: 0.81–3.69; p < 0.01). Inter-subgroup analysis showed that severe hypoglycemia (SH) increased the risk by twofold compared to non-severe hypoglycemia (NSH) RR 1.96 (95%CI: 1.38-2.78; p <0.01). In contrast, mild hypoglycemia did not significantly increase the risk of stroke compared to normoglycemia (RR 1.27; 95% CI: 0.79-2.05; p = 0.32). In terms of mortality, hypoglycemia increased the risk of mortality (RR 2.42; 95% CI: 1.59-3.68; p <0.01). Across the analyzed comparisons, severe hypoglycemia was generally associated with higher stroke and mortality risks (RR 2.56; 95%CI: 1.36-4.81; p <0.01).
Conclusion: Hypoglycemia is significantly associated with increased risks of stroke and mortality, with the greatest impact observed in SH episodes, underscoring the clinical importance of preventing SH.
References
1. Feigin VL, Brainin M, Norrving B, et al. World Stroke Organization: Global Stroke Fact Sheet 2025. Int J Stroke. 2025;20(2):132-44. doi: 10.1177/17474930241308142
2. American Diabetes Association Professional Practice Committee. 6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes-2025. Diabetes Care. 2025;48(1 Suppl 1):S128-S145. doi: 10.2337/dc25-S006
3. Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2019 Dec;50(12):e344-e418. doi: 10.1161/STR.0000000000000211
4. Singh RJ, Doshi D, Barber PA. Hypoglycemia Causing Focal Cerebral Hypoperfusion and Acute Stroke Symptoms. Can J Neurol Sci. 2021 Jul;48(4):550-2. doi: 10.1017/cjn.2020.246
5. Bree AJ, Puente EC, Daphna-Iken D, Fisher SJ. Diabetes increases brain damage caused by severe hypoglycemia. Am J Physiol Endocrinol Metab. 2009 Jul;297(1):E194-201. doi: 10.1152/ajpendo.91041.2008
6. Denorme F, Portier I, Kosaka Y, Campbell RA. Hyperglycemia exacerbates ischemic stroke outcome independent of platelet glucose uptake. J Thromb Haemost. 2021 Feb;19(2):536-46. doi: 10.1111/jth.15154
7. Ohshita T, Imamura E, Nomura E, Wakabayashi S, Kajikawa H, Matsumoto M. Hypoglycemia with focal neurological signs as stroke mimic: Clinical and neuroradiological characteristics. J Neurol Sci. 2015;353(1-2):98-101. doi: 10.1016/j.jns.2015.04.015
8. Hsu PF, Sung SH, Cheng HM, et al. Association of clinical symptomatic hypoglycemia with cardiovascular events and total mortality in type 2 diabetes: a nationwide population-based study. Diabetes Care. 2013 Apr;36(4):894-900. doi: 10.2337/dc12-0916
9. Lee AK, Warren B, Lee CJ, et al. The Association of Severe Hypoglycemia With Incident Cardiovascular Events and Mortality in Adults With Type 2 Diabetes. Diabetes Care. 2018 Jan;41(1):104-11. doi: 10.2337/dc17-1669
10. Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. Int J Surg. 2021 Apr;88:105906. doi: 10.1016/j.ijsu.2021.105906
11. Bedenis R, Price AH, Robertson CM, et al. Association between severe hypoglycemia, adverse macrovascular events, and inflammation in the Edinburgh Type 2 Diabetes Study. Diabetes Care. 2014 Dec;37(12):3301-8. doi: 10.2337/dc14-0908
12. Rana JS, Moffet HH, Liu JY, Karter AJ. Severe Hypoglycemia and Risk of Atherosclerotic Cardiovascular Disease in Patients With Diabetes. Diabetes Care. 2021 Mar;44(3):e40-e41. doi: 10.2337/dc20-2798
13. Nunes AP, Iglay K, Radican L, et al. Hypoglycaemia seriousness and weight gain as determinants of cardiovascular disease outcomes among sulfonylurea users. Diabetes Obes Metab. 2017 Oct;19(10):1425-35. doi: 10.1111/dom.13000
14. Christou MA, Christou PA, Kyriakopoulos C, Christou GA, Tigas S. Effects of Hypoglycemia on Cardiovascular Function in Patients with Diabetes. Int J Mol Sci. 2023 May 27;24(11):9357. doi: 10.3390/ijms24119357
15. Hanefeld M, Frier BM, Pistrosch F. Hypoglycemia and Cardiovascular Risk: Is There a Major Link? Diabetes Care. 2016 Aug;39 Suppl 2:S205-9. doi: 10.2337/dcS15-3014
16. Rickels MR. Hypoglycemia-associated autonomic failure, counterregulatory responses, and therapeutic options in type 1 diabetes. Ann N Y Acad Sci. 2019 Oct;1454(1):68-79. doi: 10.1111/nyas.14214
17. Chow E, Bernjak A, Williams S, et al. Risk of cardiac arrhythmias during hypoglycemia in patients with type 2 diabetes and cardiovascular risk. Diabetes. 2014 May;63(5):1738-47. doi: 10.2337/db13-0468
18. Cryer PE. Hypoglycemia-associated autonomic failure in diabetes. Handb Clin Neurol. 2013;117:295-307. doi: 10.1016/B978-0-444-53491-0.00023-7
19. Bonds DE, Miller ME, Bergenstal RM, et al. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. BMJ. 2010 Jan 8;340:b4909. doi: 10.1136/bmj.b4909
20. Zoungas S, Patel A, Chalmers J, et al. Severe hypoglycemia and risks of vascular events and death. N Engl J Med. 2010 Oct 7;363(15):1410-8. doi: 10.1056/NEJMoa1003795
21. Nakhleh A, Shehadeh N. Hypoglycemia in diabetes: An update on pathophysiology, treatment, and prevention. World J Diabetes. 2021 Dec 15;12(12):2036-49. doi: 10.4239/wjd.v12.i12.2036
22. Mattishent K, Loke YK. Meta-Analysis: Association Between Hypoglycemia and Serious Adverse Events in Older Patients Treated With Glucose-Lowering Agents. Front Endocrinol (Lausanne). 2021 Mar 8;12:571568. doi: 10.3389/fendo.2021.571568
23. Yeh JS, Sung SH, Huang HM, et al. Hypoglycemia and risk of vascular events and mortality: a systematic review and meta-analysis. Acta Diabetol. 2016 Jun;53(3):377-92. doi: 10.1007/s00592-015-0803-3
24. Li J, Ji C, Zhang W, Lan L, Ge W. Effect of new glucose-lowering drugs on stroke in patients with type 2 diabetes: A systematic review and Meta-analysis. J Diabetes Complications. 2023 Jan;37(1):108362. doi: 10.1016/j.jdiacomp.2022.108362
25. Rajati F, Rajati M, Rasulehvandi R, Kazeminia M. Prevalence of stroke in the elderly: A systematic review and meta-analysis. Interdisciplinary Neurosurgery. 2023; 23:101746. https://doi.org/10.1016/j.inat.2023.101746
26. Pirscoveanu DFV, Olaru DG, Hermann DM, Doeppner TR, Ghinea FS, Popa-Wagner A. Immune genes involved in synaptic plasticity during early postnatal brain development contribute to post-stroke damage in the aging male rat brain. Biogerontology. 2025 Feb 18;26(2):60. doi: 10.1007/s10522-025-10203-4
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Valentinus Besin, Yosi Yohanes Putra Tandi, Lisa Thalia Mulyanata, Farizky Martriano Humardani, Nita Kurniawati

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
